Abstract
INTRODUCTION: The SARS-CoV-2 coronavirus pandemic has caused more than
fifteen million infections worldwide. Our aim is to investigate the
differentiating characteristics in asthmatic patients with SARS-CoV-2
infection in the community of Castilla la Mancha. METHODS: We used the
Savana® software and its algorithm based on Big Data and artificial
intelligence, performed a retrospective search of the diagnoses of COVID
19 and asthma in the digitized medical records with positive RT-PCR
results for SARS-CoV-2, and analysed the demographic characteristics,
comorbidities, hospitalization data and deaths. RESULTS: 6,310 patients
with positive RT-PCR for SARS-CoV-2 were selected, of which 577 had a
diagnosis of asthma with a prevalence of 9.14%. The mean age in
SARS-CoV-2 (SC2) was 59 ±19 years of age and in SARS-CoV2-asthma (SC2-A)
55 ±20 years of age. SC2 included 2983 (41%) men and 3327 (59%) women,
while SC2-A included 198 (31%) men and 379 (69%) women. High blood
pressure (BP) was the most common comorbidity in both groups (51%).
2,164 SC2 (34.2%) and 131 SC2-A (22.7%) required hospitalization with
an asthma prevalence of 6.05%. 250 SC2 (3.96%) and 21 SC2-A (3.64%)
died. CONCLUSION: The prevalence of asthma in our SARS-CoV-2 positive
RT-PCR population was 9.14% and 6.05% in hospitalized patients. HBP is
the most frequent comorbidity in both groups, and smoking is the only
one with significant differences, more frequent in asthmatics. Mortality
is lower in patients with asthma